Cryptococcus Antigen (CALAS) – Quantitative

Test Information: The CrAg Lateral Flow assay aids in the diagnosis of Cryptococcosis. This assay is an immunochromatographic test system for semi-quantitative detection of the capsular polysaccharide antigens of Cryptococcus species complex (Cryptococcus neoformans...

Cryptococcus Antigen (CALAS) – Qualitative

Test Information: The CrAg Lateral Flow Assay aids in the diagnosis of Cryptococcosis. This assay is an immunochromatographic test system for qualitative detection of the capsular polysaccharide antigens of Cryptococcus species complex (Cryptococcus neoformans and...

Clostridium difficile Toxin A and Toxin B

Test Information: This is a chromatographicimmunoassay for the qualitative detection of toxins A and B from C. difficile in human feces. C. difficileis considered to be responsible for approximately 25% of the diarrhea associated with the consumption of antibiotics,...

Clostridium difficile Antigen

Test Information: Clostridium difficile GDH is a rapid qualitative enzyme immunoassay screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected of having C. difficile infection (CDI). This test does not...

Chlamydia trachomatis IgA

Test Information: Chlamydia trachomatis is the most prevalent agent of sexually transmitted diseases worldwide (400-500 million cases) and the number of infections is constantly growing, during childbirth, causing conjunctivitis or pneumonia in newborns. The Chlamydia...

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.